India to Australia: Codeine Export Trade Route
India has recorded 148 verified shipments of Codeine exported to Australia, representing a combined trade value of $6.5M USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $43.7K USD. The leading Indian exporter is SANOFI INDIA LIMITED, which accounts for 74% of total export value with 66 shipments worth $4.8M USD. On the buying side, SANOFI-AVENTIS AUSTRALIA PTY LTD is the largest importer in Australia with $3.9M USD in purchases. The top 3 suppliers — SANOFI INDIA LIMITED, SANOFI INDIA LIMITED , MEDREICH LIMITED — together control 90% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Codeine corridor is one of India's established pharmaceutical export routes, with 148 shipments documented worth a combined $6.5M USD. The route is dominated by SANOFI INDIA LIMITED, which alone accounts for roughly 74% of all export value, reflecting the consolidated nature of India's codeine manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $43.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with codeine's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 32.7%, placing it at rank #7 among India's top codeine export destinations globally.
On the import side, key buyers of Indian codeine in Australia include SANOFI-AVENTIS AUSTRALIA PTY LTD, SANOFI AVENTIS AUSTRALIA PTY LTD, SANOFI-AVENTIS AUSTRALIA PTY LTD and 13 others. SANOFI-AVENTIS AUSTRALIA PTY LTD is the single largest importer with 52 shipments valued at $3.9M USD.
Route Characteristics
- Average transit30 days
- Peak seasonQ4
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#7
- Annual growth+32.7%
- Demand growth+29.1%
- Regulatory ease83/100
Top 10 Indian Codeine Exporters to Australia
Showing top 10 of 8 Indian suppliers exporting Codeine to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SANOFI INDIA LIMITED Avg $72.7K per shipment | 66 | $4.8M | 74.2% |
| 2 | SANOFI INDIA LIMITED Avg $71.2K per shipment | 8 | $569.6K | 8.8% |
| 3 | MEDREICH LIMITED Avg $16.9K per shipment | 28 | $473.3K | 7.3% |
| 4 | J B CHEMICALS AND PHARMACEUTICALS LIMITED Avg $14.3K per shipment | 18 | $257.3K | 4.0% |
| 5 | MEDREICH LIMITED Avg $16.5K per shipment | 9 | $148.3K | 2.3% |
| 6 | CIPLA LIMITED Avg $10.8K per shipment | 10 | $108.3K | 1.7% |
| 7 | J B CHEMICALS PHARMACEUTICALS LIMITED Avg $14.2K per shipment | 6 | $85.1K | 1.3% |
| 8 | CIPLA LIMITED Avg $8.4K per shipment | 3 | $25.1K | 0.4% |
This table shows the top 10 of 8 Indian companies exporting codeine to Australia, ranked by total trade value. The listed exporters are: SANOFI INDIA LIMITED, SANOFI INDIA LIMITED , MEDREICH LIMITED, J B CHEMICALS AND PHARMACEUTICALS LIMITED, MEDREICH LIMITED , CIPLA LIMITED , J B CHEMICALS PHARMACEUTICALS LIMITED, CIPLA LIMITED. SANOFI INDIA LIMITED is the dominant supplier with 66 shipments worth $4.8M USD, giving it a 74% market share. The top 3 suppliers together account for 90% of the total trade value on this route.
Top 10 Codeine Importers in Australia
Showing top 10 of 16 known buyers in Australia receiving Codeine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian codeine in Australia include SANOFI-AVENTIS AUSTRALIA PTY LTD, SANOFI AVENTIS AUSTRALIA PTY LTD, SANOFI-AVENTIS AUSTRALIA PTY LTD , MEDREICH AUSTRALIA PTY LTD, SANOFI-AVENTIS AUSTRALIA PTY LIMITED, among 16 total buyers. The largest importer is SANOFI-AVENTIS AUSTRALIA PTY LTD, accounting for $3.9M USD across 52 shipments — representing 61% of all codeine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SANOFI-AVENTIS AUSTRALIA PTY LTD | 52 | $3.9M | 61.0% |
| 2 | SANOFI AVENTIS AUSTRALIA PTY LTD | 6 | $587.8K | 9.1% |
| 3 | SANOFI-AVENTIS AUSTRALIA PTY LTD | 8 | $569.6K | 8.8% |
| 4 | MEDREICH AUSTRALIA PTY LTD | 19 | $334.0K | 5.2% |
| 5 | SANOFI-AVENTIS AUSTRALIA PTY LIMITED | 8 | $264.4K | 4.1% |
| 6 | INOVA PHARMACEUTICALS(AUSTRALIA) PT | 18 | $257.3K | 4.0% |
| 7 | MEDREICH AUSTRALIA PTY LTD | 9 | $148.3K | 2.3% |
| 8 | CIPLA AUSTRALIA PTY LTD, | 10 | $108.3K | 1.7% |
| 9 | MEDREICH AUSTRALIA PTY LIMITED | 3 | $92.3K | 1.4% |
| 10 | INOVA PHARMACEUTICALS AUSTRALIA PT ROWN DHL SUPPLY CHAIN | 6 | $85.1K | 1.3% |
Showing top 10 of 16 Codeine importers in Australia on this route.
Top 10 Codeine Formulations Imported by Australia
Showing top 10 of 107 product formulations shipped on the India to Australia Codeine route, ranked by trade value
Australia imports a wide range of codeine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMACEUTICAL PRODUCTS - MERSYNDOL FORTE 5-30-450MG TABLETS (65610 PACK X 20) EXEMPTED MATERIAL (W/O WASTAGE) CODEINE P — accounts for $1.1M USD across 1 shipments. There are 107 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICAL PRODUCTS - MERSYNDOL FORTE 5-30-450MG TABLETS (65610 PACK X 20) EXEMPTED MATERIAL (W/O WASTAGE) CODEINE P | 1 | $1.1M | 16.9% |
| 2 | APX-PARACETAMOL/CODEINE 500-30MG TABLETS | 1 | $169.1K | 2.6% |
| 3 | PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS (294673 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) PA | 3 | $145.6K | 2.3% |
| 4 | PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS ( 295741 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) P | 3 | $145.6K | 2.3% |
| 5 | PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS ( 293972 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) P | 3 | $144.7K | 2.2% |
| 6 | PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS ( 295845 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) PTBS | 3 | $143.8K | 2.2% |
| 7 | PHARMACEUTICAL PRODUCTS -APX-PARACETAMOL/CODEINE 500-30MG TABLETS (295099 PACK X20) Exempted Material (W/O Wastage) PAR | 1 | $143.7K | 2.2% |
| 8 | PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS (294327 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) PA | 3 | $143.5K | 2.2% |
| 9 | PHARMACEUTICAL PRODUCTS - APX-PARACETAMOL/CODEINE 500-30MG TABLETS (292880 PACKX 20) EXEMPTED MATERIAL (W/O WASTAGE) PA | 3 | $142.4K | 2.2% |
| 10 | PHARMACEUTICAL PRODUCTS APX PARACETAMOL CODEINE 500 30MG TABLETS 293019 PACK X 20 Exempted Material W O Wastage PARACETA | 1 | $141.7K | 2.2% |
Showing top 10 of 107 Codeine formulations imported by Australia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 51 shipments. Transit time averages 30 days by sea.
Market Dynamics
India's codeine exports to Australia are driven primarily by a handful of large-scale manufacturers. SANOFI INDIA LIMITED with 66 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SANOFI INDIA LIMITED, SANOFI INDIA LIMITED , MEDREICH LIMITED — together account for 90% of total trade value on this route. The average shipment value of $43.7K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as apx-paracetamol/codeine 500-30mg tablets and pharmaceutical products - apx-paracetamol/codeine 500-30mg tablets (294673 packx 20) exempted material (w/o wastage) pa, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SANOFI-AVENTIS AUSTRALIA PTY LTD is the largest importer with 52 shipments worth $3.9M USD — representing 61% of all codeine imports from India on this route. A total of 16 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $6.5M
- Avg. Shipment
- $43.7K
- Suppliers
- 8
- Buyers
- 16
- Transit (Sea)
- ~30 days
- Annual Growth
- +32.7%
Reverse Direction
Australia → India — Codeine (Import)Other Codeine Routes
Unlock the Full India to Australia Codeine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 148 shipments on this route.
Frequently Asked Questions — India to Australia Codeine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Codeine to Australia?
The leading Indian exporters of Codeine to Australia are SANOFI INDIA LIMITED, SANOFI INDIA LIMITED , MEDREICH LIMITED. SANOFI INDIA LIMITED holds the largest market share at approximately 74% of total trade value on this route.
Q What is the total value of Codeine exports from India to Australia?
India exports Codeine to Australia worth approximately $6.5M USD across 148 recorded shipments. The average value per shipment is $43.7K USD.
Q Which ports does India use to ship Codeine to Australia?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 51 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 26% by air.
Q How long does shipping take from India to Australia for Codeine?
The average transit time for Codeine shipments from India to Australia is approximately 30 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Australia Codeine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 32.7% with demand growth tracking at 29.1%. The route is ranked #7 among India's top Codeine export destinations globally.
Q How many suppliers are active on the India to Australia Codeine route?
There are currently 8 active Indian suppliers exporting Codeine to Australia. The market is moderately concentrated with SANOFI INDIA LIMITED accounting for 74% of total shipment value.
Q Who are the main importers of Codeine from India in Australia?
The leading importers of Indian Codeine in Australia include SANOFI-AVENTIS AUSTRALIA PTY LTD, SANOFI AVENTIS AUSTRALIA PTY LTD, SANOFI-AVENTIS AUSTRALIA PTY LTD , MEDREICH AUSTRALIA PTY LTD, SANOFI-AVENTIS AUSTRALIA PTY LIMITED. SANOFI-AVENTIS AUSTRALIA PTY LTD is the largest buyer with 52 shipments worth $3.9M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Codeine.
- 2.Supplier/Buyer Matching: 8 Indian exporters and 16 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 148 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
148 Verified Shipments
8 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists